Conversely, exposure to S63845 disrupted BIM/MCL-1 with compensational increased BIM/BCL-2 binding, in accordance with a recent report analyzing multiple myeloma cells [54]. This evidence concerns the gene BCL2L11 and plasma cell myeloma.